1219798-97-6
Chemical Structure
Sodium 2-hydroxybutanoate-d3
- CAS No.: 1219798-97-6
- Formula:C4H4D3NaO3
- Molecular Weight:129.10
IUPAC Name: 2-(2-amino-4,5-dihydro-1H-imidazol-1-yl-2-13C)acetic-13C2 acid
InChIKey: MOSCXNXKSOHVSQ-LCZHFHQESA-M
SMILES: CC([2H])([2H])C([2H])(O)C(O[Na])=O
Biological Activity: Sodium 2-hydroxybutanoate-d3 is the deuterium labeled Sodium 2-hydroxybutanoate[1]. Sodium 2-hydroxybutanoate (2-Hydroxybutyric acid sodium) is converted from 2-Aminobutyric acid, with 2-oxobutyric acid as an intermediate metabolite[1]. Sodium 2-hydroxybutanoate is a potential biomarker for type 2 diabetes and preeclampsia[2][4]. Sodium 2-hydroxybutanoate prevents the acetaminophen (AP)-induced liver injury[3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Sodium 2-hydroxybutanoate-d3 | 99.91% | Sodium 2-hydroxybutanoate-d3 is the deuterium labeled Sodium 2-hydroxybutanoate. Sodium 2-hydroxybutanoate (2-Hydroxybutyric acid sodium) is converted from 2-Aminobutyric acid, with 2-oxobutyric acid as an intermediate metabolite. Sodium 2-hydroxybutanoate is a potential biomarker for type 2 diabetes and preeclampsia. Sodium 2-hydroxybutanoate prevents the acetaminophen (AP)-induced liver injury. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sodium 2-hydroxybutanoate (Standard) | ≥98% | Sodium 2-hydroxybutanoate is an endogenous metabolite. Sodium 2-hydroxybutanoate (2-Hydroxybutyric acid sodium) is converted from 2-Aminobutyric acid, with 2-oxobutyric acid as an intermediate metabolite. Sodium 2-hydroxybutanoate is a potential biomarker for type 2 diabetes and preeclampsia. Sodium 2-hydroxybutanoate prevents the acetaminophen (AP)-induced liver injury. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sodium 2-hydroxybutanoate | 98.0% | Sodium 2-hydroxybutanoate (2-Hydroxybutyric acid sodium) is converted from 2-Aminobutyric acid, with 2-oxobutyric acid as an intermediate metabolite. Sodium 2-hydroxybutanoate is a potential biomarker for type 2 diabetes and preeclampsia. Sodium 2-hydroxybutanoate prevents the acetaminophen (AP)-induced liver injury. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
